World News Insights
1-3 Minute Gist
Support LyrArc
Reader contributions keep LyrArc open for everyone
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Articles
LyrArc brings in selected articles from many of the world's top publications.
Articles are selected by experts and you can see the gist of the important articles.
6
Groups
LyrArc Article Gist
Shayndi Raice of the Journal interviews CEO Mark Zuckerberg, and COO Sheryl Sandberg, of Facebook, before the company's IPO.
Shayndi Raice of the Journal interviews CEO Mark Zuckerberg, and COO Sheryl Sandberg, of Facebook, before the company's IPO.
LyrArc Article Gist
Jakab says Pfizer has managed the transition to a generic version of Lipitor and loss of revenues from the blockbuster drug in a well planned manner. The branded version of Lipitor still has a 32% market share according to IMS. An approved generic version of Lipitor sold by Watson Pharmaceuticals has a 27% market share. As a result the shock of losing Lipitor revenues has been cushioned to some extent. In 2008 Lipitor comprised 26% of Pfizer sales, in 2011 this has about 14%. This was partly achieved by acquiring Wyeth in 2009. Pfizer has returned $12 billion to shareholders in dividends and share buybacks in the year ending September.
Jakab says Pfizer has managed the transition to a generic version of Lipitor and loss of revenues from the blockbuster drug in a well planned manner. The branded version of Lipitor still has a 32% market share according to IMS. An approved generic version of Lipitor sold by Watson Pharmaceuticals has a 27% market share. As a result the shock of losing Lipitor revenues has been cushioned to some extent. In 2008 Lipitor comprised 26% of Pfizer sales, in 2011 this has about 14%. This was partly achieved by acquiring Wyeth in 2009. Pfizer has returned $12 billion to shareholders in dividends and share buybacks in the year ending September.
4
Groups
LyrArc Article Gist
Wal-Mart has fallen behind competitors CVS and Walgreen in its drive to open medical clinics in its stores. Walgreens now has 350 in-store clinics, CVS 600, Target 44, and Kroger 80. Wal-mart has 149 in-store clincs in the U.S.
Wal-Mart has fallen behind competitors CVS and Walgreen in its drive to open medical clinics in its stores. Walgreens now has 350 in-store clinics, CVS 600, Target 44, and Kroger 80. Wal-mart has 149 in-store clincs in the U.S.
LyrArc Article Gist
Online sales of razors are growing rapidly, having doubled to $263 million in the 12 months through May 2015, according to Slice Intelligence. This is about 8% of the market of $3 billion. P&G Gillette division is responding by offering better prices online to compete with competitors such as Dollar Shave Club. Dollar Shave Club has about 2 million customers paying about $1 to $9 every 2 months for blades. Gillette's claim is that its Fusion ProGlide blades cost $5 a month, based on changing cartridges only once a month for 3-4 shaves per week. Gillette dominates retail sales because of its relationships with retailers, its displays inside stores, and its packaging. The online competition changes the way blades are sold, bringing better prices to customers used to paying high prices for baldes sold with "new and improved" labels.
Online sales of razors are growing rapidly, having doubled to $263 million in the 12 months through May 2015, according to Slice Intelligence. This is about 8% of the market of $3 billion. P&G Gillette division is responding by offering better prices online to compete with competitors such as Dollar Shave Club. Dollar Shave Club has about 2 million customers paying about $1 to $9 every 2 months for blades. Gillette's claim is that its Fusion ProGlide blades cost $5 a month, based on changing cartridges only once a month for 3-4 shaves per week. Gillette dominates retail sales because of its relationships with retailers, its displays inside stores, and its packaging. The online competition changes the way blades are sold, bringing better prices to customers used to paying high prices for baldes sold with "new and improved" labels.
1
Links
5
Groups
LyrArc Article Gist
Merck's decision to organize R&D using four innovation hubs in Boston, San Francisco, London and Shanghai. Merck currently lacks a large R&D presence in London and it has commercial operations in Shanghai. Experts say innovation centers enable drug companies to take advantage of academic research at an early stage. Pfizer and other companies are also pursuing a similiar strategy. The new head of R&D at Merck, Dr, Perlmutter plans to shrink staff and focus on promising areas such as immunoterapies for treating cancer and vaccines. Perlmutter comes from Amgen and is bringing people who he worked with at Amgen. The focus is also shifting to tapping the new science behind dieseases.
Merck's decision to organize R&D using four innovation hubs in Boston, San Francisco, London and Shanghai. Merck currently lacks a large R&D presence in London and it has commercial operations in Shanghai. Experts say innovation centers enable drug companies to take advantage of academic research at an early stage. Pfizer and other companies are also pursuing a similiar strategy. The new head of R&D at Merck, Dr, Perlmutter plans to shrink staff and focus on promising areas such as immunoterapies for treating cancer and vaccines. Perlmutter comes from Amgen and is bringing people who he worked with at Amgen. The focus is also shifting to tapping the new science behind dieseases.
Support LyrArc
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us